Arslan, Nuri Gülhane Askeri Tıp Fakültesi (GATF) - Nükleer Tıp Anabilim Dalı, Turkey , Üstünsöz, Bahri Gülhane Askeri Tıp Fakültesi (GATF) - Radyoloji Anabilim Dalı, Turkey , Alagöz, Engin Gülhane Askeri Tıp Fakültesi (GATF) - Nükleer Tıp Anabilim Dalı, Turkey , Uğurel, Şahin Gülhane Askeri Tıp Fakültesi (GATF) - Radyoloji Anabilim Dalı, Turkey , Öztürk, Erkan Gülhane Askeri Tıp Fakültesi (GATF) - Genel Cerrahi Anabilim Dalı, Turkey , Tufan, Turgut Gülhane Askeri Tıp Fakültesi (GATF) - Genel Cerrahi Anabilim Dalı, Turkey , Özgüven, Mehmet Ali Gülhane Askeri Tıp Fakültesi (GATF) - Nükleer Tıp Anabilim Dalı, Turkey

Selective intraarterial radionuclide radiotherapy of inoperable liver metastases with Yttrium-90 (Y-90) labeled microspheres in a patient with medullary thyroid carcinoma metastasis in the liver: first national administration

19936

Radioembolization of inoperable primary or metastatic liver cancers with Yttrium-90 (Y-90) labeled radiomicrospheres is a treatment modality with its efficacy established. It is possible to administer curative doses of radiation to the tumor tissue while preserving normal liver parenchyma to a large extent with selective intraarterial radionuclide therapy performed with Y-90 labeled microspheres. Selective intraarterial radionuclide therapy with SIRSpheres ® was approved by Turkish Ministry of Health for the treatment of inoperable liver cancers in April 2008. In this study, the results of selective intraarterial radionuclide therapy performed with SIR-Spheres® for the first time in Turkey in a 32-year-old male patient with inoperable liver metastasis due to medullary thyroid carcinoma are presented.

57

Liver tumor , radiomicrosphere , selective intra , arterial radionuclide therapy , Yittrium–90

Gulhane Medical Journal

61